nodes	percent_of_prediction	percent_of_DWPC	metapath
Perflutren—Clotting—Octreotide—thymus cancer	0.0615	0.0615	CcSEcCtD
Perflutren—Renal pain—Octreotide—thymus cancer	0.0418	0.0418	CcSEcCtD
Perflutren—Haematoma—Octreotide—thymus cancer	0.035	0.035	CcSEcCtD
Perflutren—Burning sensation—Octreotide—thymus cancer	0.0316	0.0316	CcSEcCtD
Perflutren—Influenza-like symptoms—Octreotide—thymus cancer	0.0308	0.0308	CcSEcCtD
Perflutren—Coagulopathy—Octreotide—thymus cancer	0.0282	0.0282	CcSEcCtD
Perflutren—Injection site pain—Octreotide—thymus cancer	0.0269	0.0269	CcSEcCtD
Perflutren—Hearing impaired—Octreotide—thymus cancer	0.0231	0.0231	CcSEcCtD
Perflutren—Injection site reaction—Octreotide—thymus cancer	0.0218	0.0218	CcSEcCtD
Perflutren—Wheezing—Octreotide—thymus cancer	0.0213	0.0213	CcSEcCtD
Perflutren—Influenza like illness—Octreotide—thymus cancer	0.0213	0.0213	CcSEcCtD
Perflutren—Cramps of lower extremities—Octreotide—thymus cancer	0.0202	0.0202	CcSEcCtD
Perflutren—Cardiac failure congestive—Octreotide—thymus cancer	0.0176	0.0176	CcSEcCtD
Perflutren—Hot flush—Octreotide—thymus cancer	0.017	0.017	CcSEcCtD
Perflutren—Menopausal symptoms—Octreotide—thymus cancer	0.0169	0.0169	CcSEcCtD
Perflutren—Visual disturbance—Octreotide—thymus cancer	0.0168	0.0168	CcSEcCtD
Perflutren—Anaphylactoid reaction—Octreotide—thymus cancer	0.0165	0.0165	CcSEcCtD
Perflutren—Dry skin—Octreotide—thymus cancer	0.0146	0.0146	CcSEcCtD
Perflutren—Cramp muscle—Octreotide—thymus cancer	0.0144	0.0144	CcSEcCtD
Perflutren—Bronchospasm—Octreotide—thymus cancer	0.0136	0.0136	CcSEcCtD
Perflutren—Sweating increased—Octreotide—thymus cancer	0.0134	0.0134	CcSEcCtD
Perflutren—Neuropathy peripheral—Octreotide—thymus cancer	0.012	0.012	CcSEcCtD
Perflutren—Conjunctivitis—Octreotide—thymus cancer	0.0119	0.0119	CcSEcCtD
Perflutren—Bradycardia—Octreotide—thymus cancer	0.0112	0.0112	CcSEcCtD
Perflutren—Rhinitis—Octreotide—thymus cancer	0.0111	0.0111	CcSEcCtD
Perflutren—Hypoaesthesia—Octreotide—thymus cancer	0.011	0.011	CcSEcCtD
Perflutren—Pharyngitis—Octreotide—thymus cancer	0.011	0.011	CcSEcCtD
Perflutren—Visual impairment—Octreotide—thymus cancer	0.0106	0.0106	CcSEcCtD
Perflutren—Tinnitus—Octreotide—thymus cancer	0.0103	0.0103	CcSEcCtD
Perflutren—Cardiac disorder—Octreotide—thymus cancer	0.0102	0.0102	CcSEcCtD
Perflutren—Flushing—Octreotide—thymus cancer	0.0102	0.0102	CcSEcCtD
Perflutren—Immune system disorder—Octreotide—thymus cancer	0.00997	0.00997	CcSEcCtD
Perflutren—Arrhythmia—Octreotide—thymus cancer	0.00986	0.00986	CcSEcCtD
Perflutren—Erythema—Octreotide—thymus cancer	0.0096	0.0096	CcSEcCtD
Perflutren—Back pain—Octreotide—thymus cancer	0.00929	0.00929	CcSEcCtD
Perflutren—Muscle spasms—Octreotide—thymus cancer	0.00923	0.00923	CcSEcCtD
Perflutren—Vision blurred—Octreotide—thymus cancer	0.00905	0.00905	CcSEcCtD
Perflutren—Tremor—Octreotide—thymus cancer	0.009	0.009	CcSEcCtD
Perflutren—Ill-defined disorder—Octreotide—thymus cancer	0.00891	0.00891	CcSEcCtD
Perflutren—Agitation—Octreotide—thymus cancer	0.00883	0.00883	CcSEcCtD
Perflutren—Malaise—Octreotide—thymus cancer	0.00866	0.00866	CcSEcCtD
Perflutren—Vertigo—Octreotide—thymus cancer	0.00863	0.00863	CcSEcCtD
Perflutren—Syncope—Octreotide—thymus cancer	0.00861	0.00861	CcSEcCtD
Perflutren—Palpitations—Octreotide—thymus cancer	0.00849	0.00849	CcSEcCtD
Perflutren—Loss of consciousness—Octreotide—thymus cancer	0.00844	0.00844	CcSEcCtD
Perflutren—Cough—Octreotide—thymus cancer	0.00838	0.00838	CcSEcCtD
Perflutren—Convulsion—Octreotide—thymus cancer	0.00832	0.00832	CcSEcCtD
Perflutren—Hypertension—Octreotide—thymus cancer	0.00829	0.00829	CcSEcCtD
Perflutren—Myalgia—Octreotide—thymus cancer	0.00818	0.00818	CcSEcCtD
Perflutren—Chest pain—Octreotide—thymus cancer	0.00818	0.00818	CcSEcCtD
Perflutren—Arthralgia—Octreotide—thymus cancer	0.00818	0.00818	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00812	0.00812	CcSEcCtD
Perflutren—Discomfort—Octreotide—thymus cancer	0.00808	0.00808	CcSEcCtD
Perflutren—Dry mouth—Octreotide—thymus cancer	0.008	0.008	CcSEcCtD
Perflutren—Anaphylactic shock—Octreotide—thymus cancer	0.00784	0.00784	CcSEcCtD
Perflutren—Oedema—Octreotide—thymus cancer	0.00784	0.00784	CcSEcCtD
Perflutren—Shock—Octreotide—thymus cancer	0.00771	0.00771	CcSEcCtD
Perflutren—Nervous system disorder—Octreotide—thymus cancer	0.00769	0.00769	CcSEcCtD
Perflutren—Tachycardia—Octreotide—thymus cancer	0.00765	0.00765	CcSEcCtD
Perflutren—Skin disorder—Octreotide—thymus cancer	0.00761	0.00761	CcSEcCtD
Perflutren—Hyperhidrosis—Octreotide—thymus cancer	0.00758	0.00758	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00714	0.00714	CcSEcCtD
Perflutren—Paraesthesia—Octreotide—thymus cancer	0.00704	0.00704	CcSEcCtD
Perflutren—Dyspnoea—Octreotide—thymus cancer	0.00699	0.00699	CcSEcCtD
Perflutren—Dyspepsia—Octreotide—thymus cancer	0.0069	0.0069	CcSEcCtD
Perflutren—Gastrointestinal disorder—Octreotide—thymus cancer	0.00677	0.00677	CcSEcCtD
Perflutren—Fatigue—Octreotide—thymus cancer	0.00676	0.00676	CcSEcCtD
Perflutren—Pain—Octreotide—thymus cancer	0.0067	0.0067	CcSEcCtD
Perflutren—Feeling abnormal—Octreotide—thymus cancer	0.00646	0.00646	CcSEcCtD
Perflutren—Gastrointestinal pain—Octreotide—thymus cancer	0.00641	0.00641	CcSEcCtD
Perflutren—Urticaria—Octreotide—thymus cancer	0.00623	0.00623	CcSEcCtD
Perflutren—Body temperature increased—Octreotide—thymus cancer	0.0062	0.0062	CcSEcCtD
Perflutren—Abdominal pain—Octreotide—thymus cancer	0.0062	0.0062	CcSEcCtD
Perflutren—Hypersensitivity—Octreotide—thymus cancer	0.00578	0.00578	CcSEcCtD
Perflutren—Asthenia—Octreotide—thymus cancer	0.00562	0.00562	CcSEcCtD
Perflutren—Pruritus—Octreotide—thymus cancer	0.00555	0.00555	CcSEcCtD
Perflutren—Diarrhoea—Octreotide—thymus cancer	0.00536	0.00536	CcSEcCtD
Perflutren—Dizziness—Octreotide—thymus cancer	0.00518	0.00518	CcSEcCtD
Perflutren—Vomiting—Octreotide—thymus cancer	0.00498	0.00498	CcSEcCtD
Perflutren—Rash—Octreotide—thymus cancer	0.00494	0.00494	CcSEcCtD
Perflutren—Dermatitis—Octreotide—thymus cancer	0.00494	0.00494	CcSEcCtD
Perflutren—Headache—Octreotide—thymus cancer	0.00491	0.00491	CcSEcCtD
Perflutren—Nausea—Octreotide—thymus cancer	0.00466	0.00466	CcSEcCtD
